A detailed history of Bank & Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bank & Trust CO holds 20,358 shares of BMY stock, worth $1.05 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
20,358
Previous 20,662 1.47%
Holding current value
$1.05 Million
Previous $1.17 Billion 6.25%
% of portfolio
1.01%
Previous 0.98%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 09, 2025

SELL
$53.9 - $63.11 $16,385 - $19,185
-304 Reduced 1.47%
20,358 $1.24 Billion
Q4 2024

Jan 07, 2025

SELL
$51.92 - $59.94 $37,797 - $43,636
-728 Reduced 3.4%
20,662 $1.17 Billion
Q2 2024

Jul 08, 2024

BUY
$40.25 - $52.99 $860,947 - $1.13 Million
21,390 New
21,390 $888 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $109B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bank & Trust CO Portfolio

Follow Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bank & Trust CO with notifications on news.